Schizophrenia / Schizoaffective DisorderNCT07708402
Healing Stigma Through Stories
A study testing Healing Stigma through Stories in people with Schizophrenia / Schizoaffective Disorder, run by National Yang Ming Chiao Tung University.
Trial summary
This study is the first phase of the research project. The purpose of this phase is to develop and refine a narrative-based intervention designed to reduce self-stigma among people with schizophrenia. A small pilot study will be conducted with 24 participants recruited from halfway houses in northern Taiwan. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Schizophrenia / Schizoaffective Disorder
- What is being tested?
- Healing Stigma through Stories
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 24 participants
- Where
- No sites listed yet
- Study dates
- 1 Aug 2026to Jul 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Aged 18 years or older.
- Diagnosed with schizophrenia or schizoaffective disorder.
- Clinically stable at the time of study enrollment.
- Able to communicate in Mandarin Chinese or Taiwanese.
- Able to read and write and complete study questionnaires.
Who cannot join
- Individuals who lack the capacity to provide informed consent. Decision-making capacity will be assessed using a 10-item true/false questionnaire adapted from Okoli et al. (2018). Participants who answer fewer than 7 questions correctly will be excluded. Those who answer 7 or more questions correctly will receive an additional explanation from the research team. Only individuals who demonstrate a complete understanding of the study after this explanation will be enrolled.
- Unwilling to have the intervention sessions audio-recorded.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Healing Stigma Through Stories: Learning From International Practices to Develop and Evaluate a Narrative Program for Individuals With Schizophrenia
This study is the first phase of the research project. The purpose of this phase is to develop and refine a narrative-based intervention designed to reduce self-stigma among people with schizophrenia.
A small pilot study will be conducted with 24 participants recruited from halfway houses in northern Taiwan. Eligible participants will receive the intervention, which consists of four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma. Participants will complete a workbook during the program, and the written content will be analyzed to better understand their experiences with stigma. Any personal information will be removed to protect participants' privacy. Before and after the intervention, participants will complete questionnaires on self-stigma, depression, social functioning, well-being, hope, and recovery. Information on medication use will also be collected. Group and individual sessions will be audio-recorded for research purposes. The questionnaire data and recordings will be used to evaluate the feasibility and preliminary effects of the intervention.
- Conditions
- Schizophrenia / Schizoaffective Disorder
- Being tested
- Healing Stigma through Stories
- Keywords
- schizophrenia, mix-method study, self-stigma, narrative therapy
- Medical subject headings
- Schizophrenia, Psychotic Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Healing Stigma through StoriesOther
Four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma.
| Study group | Role | What they receive |
|---|---|---|
| Healing Stigma through Stories | Experimental | Not described Receives: Other: Healing Stigma through Stories |
What is being measured
The primary outcome is the main question the study is designed to answer.
The Internalized Stigma of Mental Illness Scale
Measured: At baseline(T0) and through study completion, an average of 8 weeks
Secondary outcomes (5)
Beck Depression Inventory-II
Measured: At baseline(T0) and through study completion, an average of 8 weeks
Self-Reported Graphic version of the Personal and Social Performance Scale
Measured: At baseline(T0) and through study completion, an average of 8 weeks
Subjective Happiness Scale
Measured: At baseline(T0) and through study completion, an average of 8 weeks
Herth Hope Index
Measured: At baseline(T0) and through study completion, an average of 8 weeks
The questionnaire about the process of recovery
Measured: At baseline(T0) and through study completion, an average of 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jul 2026
- Study start1 Aug 2026 (estimated)
- Primary completionJul 2027 (estimated)
- Study completionJul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Schizophrenia / Schizoaffective DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 24 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National Yang Ming Chiao Tung University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Li-Ting Huang, National Yang Ming Chiao Tung University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07708402
- Sponsor's protocol ID
- NYCU115040AF
- Other IDs
- 115-2314-B-A49 -082 -
- Status last verified
- Jul 2026
- First submitted
- 7 Jul 2026
- Last updated
- 16 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 16 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Healing Stigma Through Stories: Learning From International Practices to Develop and Evaluate a Narrative Program for Individuals With Schizophrenia
- ClinicalTrials.gov ID
- NCT07708402
- Acronym / sponsor ID
- NYCU115040AF
- Conditions
- Schizophrenia / Schizoaffective Disorder
- Keywords
- schizophrenia, mix-method study, self-stigma, narrative therapy
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 24 participants (estimated)
- Lead sponsor
- National Yang Ming Chiao Tung UniversityUniversity, hospital or other
- Study start
- 1 Aug 2026 (estimated)
- Primary completion
- Jul 2027 (estimated)
- Study completion
- Jul 2027 (estimated)
- First posted
- 16 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is the first phase of the research project. The purpose of this phase is to develop and refine a narrative-based intervention designed to reduce self-stigma among people with schizophrenia.
A small pilot study will be conducted with 24 participants recruited from halfway houses in northern Taiwan. Eligible participants will receive the intervention, which consists of four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma. Participants will complete a workbook during the program, and the written content will be analyzed to better understand their experiences with stigma. Any personal information will be removed to protect participants' privacy. Before and after the intervention, participants will complete questionnaires on self-stigma, depression, social functioning, well-being, hope, and recovery. Information on medication use will also be collected. Group and individual sessions will be audio-recorded for research purposes. The questionnaire data and recordings will be used to evaluate the feasibility and preliminary effects of the intervention.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Healing Stigma through Stories | Experimental | Other: Healing Stigma through Stories |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Aged 18 years or older.
- Diagnosed with schizophrenia or schizoaffective disorder.
- Clinically stable at the time of study enrollment.
- Able to communicate in Mandarin Chinese or Taiwanese.
- Able to read and write and complete study questionnaires.
Key exclusion criteria (2 listed)
- Individuals who lack the capacity to provide informed consent. Decision-making capacity will be assessed using a 10-item true/false questionnaire adapted from Okoli et al. (2018). Participants who answer fewer than 7 questions correctly will be excluded. Those who answer 7 or more questions correctly will receive an additional explanation from the research team. Only individuals who demonstrate a complete understanding of the study after this explanation will be enrolled.
- Unwilling to have the intervention sessions audio-recorded.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Healing Stigma through StoriesFour group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma. | Other | Healing Stigma through Stories |
Primary outcome
The Internalized Stigma of Mental Illness Scale
Time frame: At baseline(T0) and through study completion, an average of 8 weeks
5 secondary outcomes
Beck Depression Inventory-II
Time frame: At baseline(T0) and through study completion, an average of 8 weeks
Self-Reported Graphic version of the Personal and Social Performance Scale
Time frame: At baseline(T0) and through study completion, an average of 8 weeks
Subjective Happiness Scale
Time frame: At baseline(T0) and through study completion, an average of 8 weeks
Herth Hope Index
Time frame: At baseline(T0) and through study completion, an average of 8 weeks
The questionnaire about the process of recovery
Time frame: At baseline(T0) and through study completion, an average of 8 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jul 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Schizophrenia / Schizoaffective Disorder
Not yet recruiting
Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2
SCHIZOPHRENIA 1 (Disorder), Schizo Affective Disorder
Enrolling by invitation
Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization
Schizophrenia Disorder, Schizoaffective Disorder
Recruiting
French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls
Schizophrenia / Schizoaffective Disorder, First Episode Psychosis (FEP)
Not yet recruiting
Effect of Occupational Therapy on Psychosocial Parameters and Functioning in Individuals With Severe Mental Illness
Schizophenia Disorder, Severe Mental Illness
Not yet recruiting
A Mobile App to Support Mood, Daily Routines and Medication Adherence in Adults With Severe Mental Illness
Severe Mental Illness, Bipolar Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
A study testing Healing Stigma through Stories in people with Schizophrenia / Schizoaffective Disorder, run by National Yang Ming Chiao Tung University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 16 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Li-Ting Huang, phD (+8862-28267284, lthuang@nycu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The Internalized Stigma of Mental Illness Scale (time frame: At baseline(T0) and through study completion, an average of 8 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2026.